Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Pharmaceutical Companies > Partneringreview 2006 - Stage of development (volume 4)
Category
Pharmaceutical (4989)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

Partneringreview 2006 - Stage of development (volume 4)

Published by Pharmalicensing Ltd.
Published February, 2006 Product code 36682
Content info 1386 pages
Price
US $ 2495 PDF by E-mail (Single User License)


Partneringreview 2006 - Stage of development (volume 4) published by Pharmalicensing Ltd. in February, 2006. This report consists of 1386 pages and the price starts from US $ 2495.

Introduction

Abstract

Partneringreview 2006 -- Volume 4: Stage of Development provides an in depth view into the deals and alliances by development stage announced in 2005, in a clear and accessible format. The report reviews over 2,600 deal announcements from discovery stage deals to marketed -- the full list of stages covered -- discovery, lead molecule, preclinical, phase I, phase I/II, phase II, phase II/III, pre-registration, regulatory approval, marketing and formulation stage deals. Each sector is further divided to analyze deals by company, industry sector and therapy area. Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed.

Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report. When using the PDF format in Acrobat Reader, simply click on the number to move around the report.

All the year's deals at a glance.

Want to know what your competitors are doing? Want to benchmark your deals against others in your therapeutic area or see how the finances of different deal types compare? Partneringreview 2006 brings all the 2005's deals into focus in one place.

Partneringreview is a comprehensive summary of the year's deal announcements in a clear and accessible printable format. Every deal entry includes financial information where disclosed, such as headline values and upfront and milestone payments. A new addition of an overview of financings from investors is also included in this latest edition.

Partneringreview 2006 is the full report of all the deals data collected in 2005, providing a broad perspective of deal announcements, and incorporates all six volumes.

Table of Contents

INTRODUCTION

  • About Partneringreview
  • Full contents of Partneringreview 2006
  • Review of deal making in 2005
  • Deals announced by development stage

VOLUME 4: STAGE OF DEVELOPMENT

Chapter 1: Early stage -- discovery, lead and preclinical

  • Deals in early stage by company
  • Deals in early stage by industry focus
  • Deals in early stage by therapy focus

Chapter 2: Clinical stage - phase I to Phase III

  • Deals in clinical stage by company
  • Deals in clinical stage by industry focus
  • Deals in clinical stage by therapy focus

Chapter 3: Late stage -- registration, approval and marketed

  • Deals in late stage by company
  • Deals in late stage by industry focus
  • Deals in late stage by therapy focus

Chapter 4: List of deals

GLOSSARY

Tables

  • Table 1 Top early stage type dealmaking companies in 2005
  • Table 2 Top clinical stage type dealmaking companies in 2005
  • Table 3 Top late stage type dealmaking companies in 2005

Figures

  • Fig. i.1 Deals announced by stage
  • Fig. 1.1 Announcements in early stage by company
  • Fig. 1.2 Announcements in early stage by industry sector
  • Fig. 1.3 Announcements in early stage by therapy area
  • Fig. 2.1 Announcements in clinical stage by company
  • Fig. 2.2 Announcements in clinical stage by industry sector
  • Fig. 2.3 Announcements in clinical stage by therapy area
  • Fig. 3.1 Announcements in late stage by company
  • Fig. 3.2 Announcements in late stage by industry sector
  • Fig. 3.3 Announcements in late stage by therapy area
Back to Top